טוען...
Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study
INTRODUCTION: To assess the efficacy and safety of the interleukin-1 receptor (IL-1R) inhibitor anakinra in adult patients with refractory Still's disease. METHODS: Twenty-five patients (13 males and 12 females, median age 32 years, median disease duration seven months) with Still's diseas...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3218906/ https://ncbi.nlm.nih.gov/pubmed/21682863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar3366 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|